3-Hydroxyphencyclidine (3-HPC), a breakdown product of phencyclidine (PCP), is growing attracting clinical focus due to limited data suggesting unique biological characteristics. Preliminary research indicate that https://www.pinterest.com/pin/1140888518124046392/